NCHR Testimony at FDA on Artecoll

February 28, 2003. If FDA approval is to mean anything, it should mean that the benefits outweigh the risks. The benefits are purely cosmetic, and most are not statistically-significant. We don’t know exactly what the risks are yet.

Read More »